TrialAAPS PharmSciTech2025

Predicting and Confirming Bioequivalence of Alpelisib Oral Granules and Tablets for Patients With PIK3CA-Related Disorders.

Elise Burmeister Getz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.